You are here: Industry Insights > vaccine

News List

U.S. officials say vaccinated don't need booster right now firstwordpharma
July 14, 2021
US health officials, following meeting with Pfizer, reiterated that Americans who have been fully vaccinated against COVID-19 do not need to get a booster shot at this time, as reported in the National Post.
Flu jab protects against some of the severe effects of COVID-19, including ICU admissions, sepsis and strokes, largest study of its kind suggests firstwordpharma
July 14, 2021
The flu vaccine? may provide vital protection against COVID-19, new research being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), held online this year, concludes.
Micron Biomedical Initiates First-Ever Microneedle Vaccine Clinical Trial in Children prnewswire
July 14, 2021
Micron Biomedical, Inc. ("Micron" or the "Company"), a leader in dissolving, microneedle-based vaccine and drug delivery, today announced that it has initiated a Phase 1/2 clinical trial of its microneedle-based measles-rubella ("MR") vaccine.
Flu Shot Might Help Ward Off Severe COVID drugs
July 13, 2021
A flu shot might offer some protection against severe effects of COVID-19, a new study suggests.
Pfizer to Meet With U.S. Officials About COVID-19 Booster Shot drugs
July 13, 2021
Pfizer said it will meet with U.S. officials on Monday to discuss possible authorization for a third booster shot of its COVID-19 vaccine.
Pregnant women to receive Moderna COVID-19 vaccine in clinical trial firstwordpharma
July 13, 2021
According to a posting on ClinicalTrials.gov, Moderna will begin studying its COVID-19 vaccine in pregnant women, Fox Business reported.
Why Even the Healthy Need a Primary Care Doctor drugs
July 12, 2021
A primary care doctor isn't only for when you're sick. Even folks who are generally healthy need a doctor who can help them stay that way.
COVID-19 vaccines highly effective in most people in clinical risk groups firstwordpharma
July 12, 2021
The study from Public Health England (PHE) included more than 1 million people in at-risk groups.
OMT skeptical about effectiveness of Janssen Covid-19 vaccine after two weeks firstwordpharma
July 12, 2021
The Netherlands' Outbreak Management Team (OMT) expressed doubts about whether Johnson & Johnson's single-dose COVID-19 vaccine offers sufficient protection against the Delta variant, reported NL Times.
Japan releases study on 'Moderna arm' reaction firstwordpharma
July 12, 2021
A research team of the Japanese government has released results from its first study on a delayed reaction to Moderna's coronavirus vaccine, reported NHK WORLD-JAPAN.